The Asia Pacific Blood Collection Devices Market would witness market growth of 6.7% CAGR during the forecast period (2021-2027).
With the expanding digitization, various organizations are introducing online sites that show the list of tests they offer. They would assign a person who will collect the sample of blood from the patients’ residence. This gives convenience to the patients. Even they are not required to go and gather the reports from the lab rather the reports are sent to them digitally through an email. These advancements have increased the requirement for sanitized and cleaned blood collection devices.
Although, the standard approach to drawing blood by venipuncture has been supplanted by another device which is pain-free option for collecting blood. The needless blood drawing system draws enough amount of blood used for various tests, in between the same time as taken by a standard method.
Cancer is one of the leading diseases in the Asia Pacific region. It is estimated that cancer was the cause of deaths for around 4.5 million deaths in the region in 2016. The highest cases of cancer were founded in Australia that is around 468.0 people per 100,000. Along with this, China accounted 4.3 million new cancer cases and 2.9 million cancer deaths in the region.
The annual report of 2020-21 by the Department of Health & Family Welfare, shows that four tribal districts of the state have accounted for 75% of the present cases of sickle cell anemia. Alirajpur, Anuppur, Dindori, Chhindware districts in Madhya Pradesh had reported 4655 cases of sickle cell anemia.
The China market dominated the Asia Pacific Blood Collection Devices Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $652.1 million by 2027. The Japan market is estimated to grow at a CAGR of 6% during (2021 - 2027). Additionally, The India market would exhibit a CAGR of 7.3% during (2021 - 2027).
Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centres, & Nursing Homes; Diagnostic & Pathology Laboratories, Blood Banks and Others. Based on Product, the market is segmented into Blood Collection Tubes, Needles & Syringes, Blood Bags, Blood Collection Systems/Monitors and Lancets. Based on Tubes Type, the market is segmented into Plasma/whole-blood Tubes and Serum Tubes. Based on Plasma/whole-blood Tubes Type, the market is segmented into EDTA Tubes, Heparin Tubes, Coagulation Tubes, Glucose Tubes and Others. Based on Tubes System Type, the market is segmented into Vacuum Tubes and Non-Vacuum Tubes. Based on Method, the market is segmented into Manual Blood Collection and Automatic Blood Collection. Based on Application, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Blood Collection Devices Market is Projected to reach USD 8 Billion by 2027, at a CAGR of 6.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sarstedt AG & Company, ICU Medical, Inc., Grifols, S.A., Retractable Technologies, Inc., Quest Diagnostics Incorporated, Becton, Dickinson and Company, Haemonetics Corporation, Terumo Corporation, Fresenius SE & Co. KGaA, and Cardinal Health, Inc.
By End User
By Product
By Tubes Type
By Plasma/whole-blood Tubes Type
By Tubes System Type
By Method
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
